Podcasts about Surescripts

Surescripts facilitates over 24 billion health data transactions annually, with e-prescribing only making up a small portion, highlighting its expansive role in health data interoperability. In this episode, Frank Harvey, CEO of Surescripts, discusses his company's mission to lower healthcare costs, improve quality, and enhance patient safety through its vast health intelligence network. He elaborates on the significant savings generated by electronic prescriptions by reducing administrative burdens and medication errors. Frank underscores the critical importance of interoperability for clinical decision-making and Surescripts' role as a Qualified Health Information Network, as well as its commitment to supporting the Sequoyah Project. He also highlights the need for collaborative care, especially given the primary care provider shortage, emphasizing the role of pharmacists.  Tune in and learn how Surescripts' work improves the e-prescribing process, enhances real-time prescription benefits, and streamlines prior authorizations! Resources: Connect with and follow Frank Harvey on LinkedIn. Follow Surescripts on LinkedIn and visit their website.

Episode 46: Pharmacy Interoperability: Challenges, Opportunities, and Urgency Host Tony Schueth leads an engaging discussion on pharmacy interoperability, a topic at the center of a recently published POCP white paper funded by the NCPDP Foundation and supported by Surescripts. Joining Tony as guests are, John Hill, Executive Director of the NCPDP Foundation, and Larry King, Director of Intelligent Prescribing at Surescripts, to unpack the white paper's findings and explore the future of pharmacy's role in patient care. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

About Frank Harvey:Frank Harvey is the CEO of Surescripts, a company aiming to we convene healthcare organizations nationwide to simplify how health intelligence is shared. Frank is an experienced chief executive and investor and has held numerous senior leadership roles during his more than 35-year career in the healthcare technology, pharmacy and pharmaceutical sectors. His leadership philosophy is to treat every person with respect, keep communication honest, and always have a bias for action. When Frank isn't working, he and his wife support their local Boys & Girls Clubs. They are also passionate defenders of clean water, working with local organizations to address the significant issue of toxic algae in local rivers.Things You'll Learn:Electronic prescribing has significantly reduced medication errors, administrative costs, and physician/pharmacist callbacks, with an estimated annual savings of $140 billion for the US healthcare system.Interoperability allows for better clinical decisions by making a comprehensive patient history accessible, improving health outcomes.The nation is facing a shortage of primary care providers, so pharmacists are in the perfect position to be integrated into the care team, making better medicine treatment and delivery. Surescripts is part of the Healthcare community and has partnerships with pharmacies, PBMs, EHRs, and health systems, all working together to improve the process of healthcare.Implementing real-time prescription benefits can reduce healthcare costs by helping physicians select more cost-effective treatment options.Resources:Connect with and follow Frank Harvey on LinkedIn.Follow Surescripts on LinkedIn and visit their website.

In this episode of The Dish on Health IT, host Tony Schueth leads an engaging discussion on pharmacy interoperability, a topic at the center of a recently published POCP white paper funded by the NCPDP Foundation and supported by Surescripts. Joining Tony as guests are, John Hill, Executive Director of the NCPDP Foundation, and Larry King, Director of Intelligent Prescribing at Surescripts, to unpack the white paper's findings and explore the future of pharmacy's role in patient care.The conversation begins with Tony laying the foundation for the discussion by defining pharmacy interoperability as the seamless, bi-directional exchange of health information between pharmacy care settings and the broader healthcare ecosystem. This connectivity ensures that data flows effortlessly without adding complexity to the workflows of pharmacists or other providers. Tony highlights the POCP white paper, which outlines critical opportunities and challenges in achieving this vision. The document calls for leveraging standards and technology to integrate pharmacists as key contributors to care teams, addressing  medication management and broader clinical services.John Hill and Larry King bring their unique perspectives to the conversation. John shares insights into how the NCPDP Foundation is focused on grants that expand the pharmacist's role, improve patient safety, and enhance access to care. He emphasizes that the white paper marks a pivotal step toward identifying gaps in interoperability and opportunities to engage pharmacists more fully in patient care. Larry draws from his experiences as a pharmacist and industry leader, highlighting the complexity of patient needs and the roadblocks that prevent pharmacists from working to the highest and best purpose of their license. Both guests underscore the need for workflow-friendly solutions to reduce administrative burdens and allow pharmacists to spend more time on meaningful, patient-centered work.The discussion delves into the growing role of pharmacists, who are increasingly stepping beyond dispensing medications to provide direct patient care services, including immunizations, chronic disease management, and comprehensive medication reviews. Tony and his guests agree that pharmacies are uniquely positioned to fill gaps in care, especially in underserved areas, and to offload basic services from overburdened primary care practices. However, for pharmacies to step into this larger role, significant progress is needed in interoperability, reimbursement models, and technology adoption.A key focus of the conversation is the critical role of standards in enabling interoperability. John elaborates on how NCPDP works to ensure data can be exchanged seamlessly, highlighting their collaboration with HL7 on standards like the eCare Plan. He explains that standards not only ensure data consistency across systems but also reduce the burden on users by integrating into existing workflows. Larry adds that Surescripts' efforts to implement interoperable solutions, such as Qualified Health Information Networks (QHINs) under TEFCA, demonstrate the potential of standards to create a nationwide framework for secure data exchange.The guests also discussed the importance of using sustainable financial models to incentivize investment in interoperability. Larry points out that while there are some reimbursement programs for clinical services, inconsistencies remain a significant barrier. Both guests stress that the industry must develop scalable payment models that align with pharmacists' expanded roles and address the technology investments required to connect pharmacy systems with the broader care continuum.Emerging technologies like AI are also prominently featured in the discussion. Larry shares how Surescripts is leveraging AI for tasks like parsing patient instructions and monitoring network activity for compliance issues. John highlights NCPDP's efforts to explore how AI can support standards adoption and governance. Both agree that while AI offers enormous potential to optimize pharmacy workflows and enhance clinical insights, it must be implemented cautiously, with safety and security as top priorities.As the episode nears its conclusion, the guests reflect on the ideal future state of pharmacy interoperability. Larry envisions a world where patients experience seamless care, with providers and pharmacists having immediate access to comprehensive, accurate health information. This would eliminate redundant data collection, reduce errors, and enable faster, more informed decision-making. John echoes this vision, emphasizing that interoperability can empower pharmacists to operate at the top of their licenses, improving patient outcomes and addressing provider shortages.Tony closes the discussion by encouraging listeners to take actionable steps, such as engaging with workgroups like NCPDP's Work Group 20, reviewing the POCP white paper, and participating in industry initiatives that drive interoperability forward. John and Larry emphasize the urgency of acting now, describing this as a once-in-a-generation opportunity to create lasting change in healthcare delivery.For more insights and resources, including links to the white paper and details on key industry initiatives, check the episode summary. Subscribe to The Dish on Health IT on Apple Podcasts, Spotify, or Healthcare Now Radio to stay informed. Let's continue the journey toward a more connected and efficient healthcare system—because health IT is a dish best served hot!Reference Links: POCP Pharmacy Interoperability Whitepaper: https://info.pocp.com/pharmacy-interoperability-whitepaper NCPDP Foundation abridged results report: https://ncpdpfoundation.org/pdf/PharmacyInteroperability_AbridgedResults.pdf  NCPDP Foundation website (for grant proposals in connection with the CTA of future opportunities for grants): https://ncpdpfoundation.org/home.aspx  NCPDP Standards website (for encouraging involvement/collaboration in WGs in connection with the CTA of getting involved/supporting the mission): https://standards.ncpdp.org/  Surescripts Blog, "Ready for Action: Advancing Pharmacy Interoperability": Preparing Pharmacy with Technology to Participate in Healthcare Interoperability | Surescripts  

Prior Authorization is a not a popular topic. In fact, we have not found many organizations willing to talk about it. Simply put, it is a complex challenge. We were pleasantly surprised when Frank Harvey, the CEO of Surescripts was willing to come on-camera to share the work they are doing in this area. Surecripts is collaborating with Cleveland Clinic and OptumRx to streamline the prior authorization process. What used to take days or hours can now be completed in seconds – without changing physician workflows. This is possible through careful coordination of data between the provider, payer, and Surescripts. This advancement not only ensures patients can access critical therapies sooner, but also reduces provider burnout. For now, this process is only for a limited number of therapeutic areas, but Surescripts plans to expand to more in the coming year. Learn more about Surescripts at https://surescripts.com/ Find more great health IT content at https://www.healthcareittoday.com/

As an official press support sponsor for HLTH, the Pharmacy Podcast Network had the privilege of capturing insights and conversations from key participants, including Matthew Higham from IDEO, Shaheen Lakhan MD, CMO of Click Therapeutics, Christine Kim with Medme Health, and Melanie Marcus, Chief Marketing & Customer Experience Officer at Surescripts. The series aims to empower pharmacists by illuminating the vital role of digital health in shaping the future of pharmacy care. Independent Pharmacy Cooperative (IPC) played a significant role at HLTH as the only technology platform and trade group representing Independent Community Pharmacy. Present at innovation booth number 4240, IPC showcased its iCare+ digital health platform, designed specifically for independent community pharmacies. With approximately 18,000 independently owned pharmacies operating across the U.S., IPC is committed to enhancing public health, especially amid the ongoing pharmacy desert crisis. “Community pharmacies are critical healthcare access points for many Americans, and it is essential that we equip them with the digital tools they need to thrive in today's evolving healthcare landscape,” said [IPC Representative's Name], [Title] at IPC. “Through our presence at HLTH and the insights shared in this podcast series, we hope to inspire pharmacists to embrace digital health solutions and advocate for their pivotal role in patient care.” The three-part podcast series will delve into the innovative ideas presented at the conference, emphasizing the intersection of technology and pharmacy practice. Listeners can expect to gain valuable perspectives on how digital health is transforming pharmacy services and enhancing patient care. The Pharmacy Podcast Network invites pharmacists, healthcare professionals, and all interested parties to tune in to this enlightening series, which underscores the importance of embracing change and innovation within the pharmacy sector. Together, we can ensure a brighter future for pharmacy care in the U.S. ### About Pharmacy Podcast Network:
The Pharmacy Podcast Network is a leading resource for pharmacy professionals, providing a platform for sharing insights, trends, and innovations in the pharmacy industry. Through engaging podcasts and expert discussions, the network aims to educate and empower pharmacists to navigate the evolving healthcare landscape. About Independent Pharmacy Cooperative (IPC):
Independent Pharmacy Cooperative (IPC) is dedicated to supporting independent pharmacies with innovative solutions and advocacy. IPC empowers pharmacists through technology, collaboration, and education, ensuring they remain vital players in public health and patient care.

o Qualified Health Information Network Updates | Surescripts https://surescripts.com/qhin o Our QHIN Use Case Guide: 17 Clinical & Business Scenarios | Surescripts https://surescripts.com/insights/QHIN-use-case-guide o Pharmacy Workgroup - The Sequoia Project https://sequoiaproject.org/interoperability-matters/pharmacy-workgroup/ o NCPDP Foundation Funds $110,000 Research Grant to Assess Current Pharmacy Technology Landscape  https://finance.yahoo.com/news/ncpdp-foundation-funds-110-000-180000004.html?guce_referrer=aHR0cHM6Ly93d3cuYmluZy5jb20v&guce_referrer_sig=AQAAAIJyZe5sHdXjPNzFgnwXqgUU_Eg0PfSR3ujwQx2hVeUy9Fqpfdn4Qai4RJuXAN71hk1y3iU4VICwfOjE84yqWNbw4LzW7a7rvL_a8pwf0AIK3KR5OM-mH4aVi-7zTloyln68wDz47PqN874PMkajYcirN6gSvhukhO3LyfZTUxBh&guccounter=2

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Bayer has developed a successful audience targeting strategy that drives meaningful engagement, with Crossix audience segments optimizing campaigns and aligning messaging more closely with the patient journey. This precision targeting has proven effective in reaching the most qualified audience and increasing engagement.Philips issued a fix for ventilator problems linked to injuries and deaths, Siemens Healthineers received FDA approval for a 3D mammography system, and Synchron's brain-computer interface technology met safety goals. Additionally, the wearables market is expected to see growth, while the FDA missed a target date for releasing rules on pulse oximeters. Medtech Dive provides insights on medical technology trends and top conferences in 2025.A private equity firm, TPG, is set to acquire a majority stake in e-prescribing giant Surescripts. HCA's Mission Hospital in North Carolina faces challenges after Hurricane Helene, while UHS has been forced to pay significant damages related to child sexual abuse allegations. Efforts to combat burnout among healthcare workers are highlighted, along with sponsored content on safeguarding healthcare against cybercrime.Eli Lilly is investing $4.5 billion in a new manufacturing and research center in Indiana, while Amgen faces a class action lawsuit and Johnson & Johnson invests $2 billion in a North Carolina facility. Bayer, J&J, and Pfizer are collectively laying off nearly 500 employees, with new developments in cFDNA methylation assays and royalty financing for biopharma companies. ImmunityBio is also undergoing layoffs in California.Roche is facing an $8 billion sales gap due to biosimilar competition, prompting investments in new blockbuster drugs. Kailera Therapeutics has secured funding for obesity drugs, and the cell and gene therapy industry is experiencing rapid growth. Pharmavoice covers these topics and more in their daily newsletter.2seventy Bio is close to reaching cash flow breakeven, attributing their survival to transparency and a committed staff. Pfizer's withdrawal of sickle cell therapy Oxbryta has raised questions among investors. Royalty financing has become crucial for biopharma companies as traditional fundraising methods falter. Lilly's drug pricing practices are under scrutiny compared to Novo Nordisk. Various updates on investments, layoffs, and legal actions can be found on Biospace's website.

On #TWIRx "This Week in Pharmacy" --we start out with the WORLD WIDE Celebration of Pharmacists, World Pharmacist Day 2024, thank you to all the 4-Million Pharmacists on planet Earth. On September 25, 2024, the global community came together to celebrate World Pharmacists Day, shining a spotlight on the invaluable role pharmacists play in safeguarding public health. (Shout out to Katrina Azer & Anisha Patel)  HARMACY Film -- huge announcement from Dr. Anaïs Webster- Mennuti, Dr. Kristin Speer, and Marie Wilda! Go to HarmacyFilm.com  Thank you Josh Kent from Cannabis Pharmacy, forwarding education, programs to support independent pharmacy businesses, and delivering highest quality products, check them out CannabisPharmacy.com -- and the Education leaders from the Answer Page with Dr. Stephen Corn, M.D. and Dr. Meredith Fisher-Corn, M.D, they joined the Pharmacy Podcast Network for reliable education for healthcare providers.  Thank you Sykes & Company for your services for Pharmacy Owners and accounting management to 'Master the Margins' of your businesses. The Road-Trip Guy is back with another 'Pharmacy CrossRoads' host Bruce Kneeland. This episode is about growing your compounding pharmacy business. We're proud of the Pediatirc Pharmacist leaders, 'Perfecting Peds' and their latest podcast episode on CFTR (Cystic fibrosis), take a listen!  Cardinal Health is focused on 'Why Independent Pharmacy' with Barry Christensen on 'Counter Talk' podcast --this is a great podcast about why it's time to build your community pharmacy, Cardinal Health is ready help build your pharmacy in 2025.  What's QHIN and how is Surescripts leading the way in 'qualified health information networks' will impact healthcare. We had a wonderful discussion lead by Dr. Simi Burn, PharmD, with special guests Ashton S. Maaraba, J.D. with IPC and Ritesh Patel with FINN Partners for being part of this discussion about #DigitalHealth inside Community Pharmacy today.  The 50 Most Influential People in Pharmacy Awards are getting ready to launch! Who do you think is an influential leader in Pharmacy Care? We're so proud to be launching the 4th #Pharmacy50 Awards in October 2024. Shout Out to the # 1 for 2023, Dr. Nadia Ahmad, PharmD --with Walgreens. Thank you Nadia for a special recognition of my work in pharmacy, thank you.  First featured guest today on TWIRx is a specialty pharmacy 'Slayer of Healthcare Barriers' Jennifer Noonan, MSN, RN, with Accessia Health, helping patients find funding for their medications when all hope seems lost, this company fights for the patient's pharmacy care.  Perigon Pharmacy 360, President Dr. Chris Antypas, PharmD., will be featured at the NASP Annual Event on the PPN's PRess coverage of the conference and he's here with us on TWIRx. Chris shares about how his specialty pharmacy is combining technology, pharmacy care plans, specialty & rare disease specialty pharmacists to innovate pharmacy care.  Shaun Jensen with JB Consulting will be at NASP ready to talk about helping Specialty Pharmacies build custom systems, software programs, and APIs to make your workflow, your mobile apps, and how to best leverage A.I. to help dial into your specialty pharmacy operations on another level. Shaun and his team build powerful programs specific to your operations needs. We can't wait to talk with Shaun in Nashville.  Thank you Shelia Arquette, CEO of the NASP for your unwavering support of Specialty Pharmacy excellence. Your impact on specialty care has been incredible. See everyone in Nashville. 

o justin.mcmartin@surescripts.com o Qualified Health Information Network Updates | Surescripts https://surescripts.com/qhin o Our QHIN Use Case Guide: 17 Clinical & Business Scenarios | Surescripts https://surescripts.com/insights/QHIN-use-case-guide o Pharmacy Workgroup - The Sequoia Project https://sequoiaproject.org/interoperability-matters/pharmacy-workgroup/ New boost

About Scott Barclay:Scott Barclay is a Managing Director at Insight Partners based in Palo Alto. His Computational Care thesis envisions the future of US and global healthcare built at the intersection of empathy and scalable technology.  Scott's early career traversed capital markets with Banc of America Securities in Europe and the US, The Boston Consulting Group, and CVS Health. At CVS and then after, Scott helped create and scale the nation's e-prescribing ecosystem, running iScribe (acq Allscripts) and as Chief Strategy Officer of Surescripts.  Prior to Insight, Scott built his investing career as a healthcare angel investor and advisor (NaviHealth, Doximity, Elation) and, from 2015 – 2020, as a Partner at DCVC, a world-class early-stage deep tech venture capital firm, where he was a director or observer on the Boards of companies like Carbon Health, Freenome, SafelyYou, and many others. Things You'll Learn:The three big themes that are set to revolutionize healthcare investment.The art and science behind Insight Partners' long-term investment and operational support strategies.Navigating valuation adjustments in turbulent markets and fostering founder relationships.The investment wisdom in an era of market recalibration—what it really takes to write the check.Sustainability and profitability: Scott's forecast on public exits for health tech startups.Resources:Connect with and follow Lynne on LinkedIn.Learn more about Insight Partners on their LinkedIn and website.

Fourth week of July, what'd you miss in vet med?Celebrating our 1 year anniversaryCambridge genome sequencingPetco new CEOE-ScriptingProvet Cloud and CVS GroupDon't miss KC Animal Health Corridor SummitSubscribe to the Fountain Report weekly newsletter: https://bit.ly/3JTYjRzHelpful links:Exonic Short Interspersed Nuclear Element Insertion in FAM161A Is Associated with Autosomal Recessive Progressive Retinal Atrophy in the English Shepherd2024 Animal Health Summit

This is the Pharmacy Podcast Network's Press & Media Coverage posts show of AXS 2024 the ASEMBIA Specialty Pharmacy Business Summit held on April 28 through May 3rd in Las Vegas at the Wynn. With over 8,000 attendees, this was a special 20th year celebration of the Asembia gathering. In this episode we talk with RxPreferred, a different kind of PBM, NASH, a medical traveling company with a specialty pharmacy focus, FINCH Specialty Pharmacy Marketing, Outcomes, leading in value based care technology, JB Consulting, Forsyth Health, Surescripts, and the Chief Strategy Officer at Asembia.  Jeff Malone - RxPreferred Meagan Williams - RxPreferred Mike Agostino - NASH Nicolle McClure - FINCH Larry Stephenson - Outcomes Shaun Jensen -  JB Consulting Steve Davis - Forsyth Health Cecila Byers PharmD - Surescripts Tommy Cohn - Chief Strategy Officer at Asembia

This is the Pharmacy Podcast Network's Press & Media Coverage posts show of AXS 2024 the ASEMBIA Specialty Pharmacy Business Summit held on April 28 through May 3rd in Las Vegas at the Wynn. With over 8,000 attendees, this was a special 20th year celebration of the Asembia gathering. In this episode, we talk with 3 executives from Accessia Health, Chief Information Officer of Surescripts, Blue Cross of California, Deloitte, the NASP, and STACK workflow systems.   Accessia Health - Tiera Green Accessia Health - Dave Griffiths DrFirst - Andrew Burns Blue Shield of California - Dr Alison K Lum Deloitte - George Van Antwerp NASP - Shelia Arquette STACK - Jonathan Ogurchak PharmD

This is the Pharmacy Podcast Network's Press & Media Coverage posts show of AXS 2024 the ASEMBIA Specialty Pharmacy Business Summit held on April 28 through May 3rd in Las Vegas at the Wynn. With over 8,000 attendees, this was a special 20th year celebration of the Asembia gathering. In this episode, we talk with 3 executives from Accessia Health, Chief Information Officer of Surescripts, Blue Cross of California, Deloitte, the NASP, and STACK workflow systems.   Accessia Health - Tiera Green Accessia Health - Dave Griffiths DrFirst - Andrew Burns Blue Shield of California - Dr Alison K Lum Deloitte - George Van Antwerp NASP - Shelia Arquette STACK - Jonathan Ogurchak PharmD

For a full transcript of this episode, click here. I'm gonna encore this episode with David Scheinker, PhD, for several reasons; but here's a big one: Why are we as an industry not doing what David Scheinker suggests in this episode? Why are we not doing, I don't know, kinds of logical things to reduce admin burden in this country when everyone agrees admin burden is a problem? But let me back up for a moment for context. Two things happened since this show originally aired. One is that I was invited to a fireside chat by the Advisory Board to talk with Abby Burns, one of the amazing hosts over at Radio Advisory; and we talked about value in the healthcare industry. And if you define value as benefit divided by costs, and you can cut costs—like cut admin burden costs in half—then you have created some really nice communal value, which we talked about at length during that aforementioned fireside chat. Here's the other thing that happened since this show originally aired. I read the book by Mike Leavitt, mainly because Steve Schutzer, MD, kept talking about it. The title of the book is Finding Allies, Building Alliances. Maybe I will do a book report about this at some point, but let me share a couple of key quotes just to get the party started here. Mike Leavitt wrote, “A diverse alliance, well led and well managed, can bring resources to bear on a problem that no organization can match—even the largest of organizations. The synergy of resources—from financial to intellectual—can deal effectively with a wide range of issues confounding organizations today.” I found that very interesting. Here's the second quote, which deals with what the top reason is that such diverse alliances may wish to hook up. “[It's] a common pain: A shared problem that motivates people and groups to work together in ways that could otherwise seem counterintuitive.” Hmm … so, back to administrative burden. Let's review the facts that David Scheinker, PhD, shares in the interview that follows. He says any given transaction will cost provider organizations 14% of the total transaction costs to manage to get paid. Yes, it costs 14% of a transaction merely to get paid for the transaction. This is a big reason why both Peter Hayes, in the episode with him (EP424), and also Marshall Allen (EP425) talk about for why cash prices can be a whole lot less than going through insurance prices because you can skip a lot of insurance burden. Now, on the payer side, add to that 14% an additional 5% to 15% to pay said transaction. That 30% of healthcare is waste stat that keeps getting tossed around. Listen to the show with Will Shrank, MD (EP413) for more on that. But, yeah … here's 20% to 30% of every transaction that is waste. And we haven't even gotten into redundant care or inappropriate back surgery yet. Our industry spends up to 30% of our money just trying to get paid and pay. Here's a case study for you. You know who has already solved for this whole “it's really hard to get paid and pay” dilemma? Derivative traders. It used to cost derivative traders $100,000 to do a contract, any given contract. And they worked together and got this down to $5000 by doing some of the stuff that David Scheinker talks about in the show. And, I don't know, I feel like the healthcare industry could also do this, too, if they wanted to. But there are a whole bunch of reasons why our industry cannot seem to get together and be as ruthlessly practical as derivative traders—or banks, who have figured out how to work together to process credit cards to reduce their own common pain. Here are but a few of the reasons, potentially, why the healthcare industry doesn't get together to reduce administrative burden in some of the ways that Dr. Scheinker talks about. 1. Some organizations actually make a lot of money off of that transactional waste. As but one example—and not to just pick on one, but we don't have all day—how about some RCM (revenue cycle management) companies who may or may not be owned by the same vertically integrated stacks as the payers themselves? As I have said any number of times, one person's—or potentially an entire country's, as the case may be—one party's waste, is somebody else's honeypot; and I am not sure if this is any exception. 2. Legacy technology and data systems and all the sunk costs therein 3. As Kaye Davis and Katrina Hubbard reminded me about the other day, there are some serious regulations in healthcare due to everybody being a vendor of CMS that adds a layer of regulatory complication to many collaborations. Also, state laws sometimes have an unintended side effect of making it tough to collaborate. Now, are there any precedents for this type of collaboration in the healthcare industry? Yeah, actually Surescripts, which, don't forget, was created by an alliance of PBMs (pharmacy benefit managers) who worked together because they all wanted to enable e-prescribing and needed a joint platform to do it. Look, I could say a lot about this one, but nonetheless, so much of what gets talked about in the show today with Dr. David Scheinker is very, very actionable. Just want to note that since David Scheinker was on the show, he and his team have done some major research over the past few years into ways that contracts can be standardized. If enough of you reach out and say that you're interested, we, for sure, can have David come back on the show and discuss. David Scheinker, PhD, is a clinical professor of pediatrics. He's the executive director of systems design and collaborative research at Stanford Children's Health. He also founded and directs SURF Stanford Medicine. And with that, here is your original episode. Administrative costs in the United States have a bad rap. You don't have to look too far to find an article about how there's now, like, 10 administrators for every 1 physician in this country. Or 3 to 4 billing people for every physician. Or consider what Dan O'Neill was talking about in episode 359. He was talking about IPAs (independent physician associations) and other managed care entities. As Dan mentions, contracting with some of these IPAs is like an “I love 1990” flashback. The contracting process transpires via mail. Not email, mind you. Mail. Like, stick-a-stamp-on-the-envelope mail. So, in sum, there's a lot of pretty well-founded complaining about administrative costs in this country. A lot of this administrative stuff is truly inefficient and a fantastical waste of time. So, here we are freaking out about staffing shortages, overlooking that doctors at the heights of their careers are spending some percentage of their time not counseling, treating, or diagnosing patients but twiddling their thumbs on hold with one insurance company or another slowly burning out by the inefficiency of it all. Or doing pajama time, and we all know that too much pajama time means also burnout on a silver platter. So then, let's get granular here. If we're trying to quantify admin costs, how you do that is to quantify how much each transaction costs. How much does it cost to send a bill and get paid for it? How much does it cost to file an appeal and a denial of a prior auth? Add all those transactions together and you get the full cost of the administrative burden. In this healthcare podcast, we're digging into a paper about admin costs written by David Scheinker, PhD (my guest today); Barak Richman, PhD, JD; Arnold Milstein, MD, MPH; and Kevin Schulman, MD, MBA. I have the pleasure of speaking with David Scheinker, PhD (as I mentioned), who is the lead author on this paper. Just to underline a major takeaway from this conversation with Dr. David Scheinker, he reiterates a recommendation to eliminate a big proportion of administrative costs. I guess I should say spoiler alert here, but the major takeaway/recommendation is this: Standardize healthcare contracts between payers and providers. Every payer and every provider finds one contract template and uses it. I don't mean one template per payer or per provider, although that probably would be a revelation in and of itself. But I mean that all payers use one basic provider contract. A couple of specifics here: The template that I'm referring to (and that Dr. David Scheinker is referring to) consists of parameters. What do I mean when I say parameters? Consider what Airbnb does when you're looking for a place to stay, as an example. How many bedrooms (that's a parameter)? How many bathrooms (that's a parameter)? How many amenities (that's a parameter)? After everybody picks their standard set of parameters, at that point, all parties can negotiate and come up with whatever they want for what is the price of an extra bedroom or whatever value you're gonna assign to that parameter. Go nuts there, but from a data collection and analytic perspective and a getting paid perspective, it is way easier to do it that way—meaning it's way easier to execute and report when all of the contracts use the same parameters. Also, you can build tech to do a lot of that because you don't have to write algorithms with exponential variables. Also mentioned in this episode are Abby Burns; Michael Leavitt; Steve Schutzer, MD; Peter Hayes; Marshall Allen; William Shrank, MD; Kaye Davis, MPH; Katrina Hubbard; Dan O'Neill; Barak Richman, PhD, JD; Arnold Milstein, MD, MPH; and Kevin Schulman, MD, MBA. You can learn more by connecting with David on LinkedIn and following him on X (Twitter).   David Scheinker, PhD, started his career as a research mathematician and switched to healthcare operations to work on an interdisciplinary team and have a more immediate impact. He is a clinical professor of pediatrics, the executive director of systems design and collaborative research at Stanford Children's Health, and a member of the Clinical Excellence Research Center (CERC) at Stanford University. He founded and directs SURF Stanford Medicine, which brings together students and faculty from the university with physicians, nurses, and administrators from the hospitals. He studies clinical care delivery, hospital operations, sensor-based and algorithm-enabled telemedicine, the socioeconomic factors that shape healthcare, and healthcare policy.   10:39 What's the quantitative administrative cost in an average transaction? 11:05 What's the quantitative administrative cost in a healthcare transaction? 11:58 What does the healthcare billing and administration cost add to the US's overall healthcare spend? 12:53 Is it possible to cut billing and administrative costs in healthcare? 14:17 “In some ways, the problem for healthcare should be simpler.” 15:30 What does the complexity of the current system look like in a doctor's office? 18:42 How did David go about studying healthcare administrative costs? 21:34 “It doesn't have to be simple; it should be standardized.” 24:50 What would be the pushback on standardizing contracts in healthcare? 25:43 Why is it possible to gain more value by losing customization in contracts? 27:20 “Never let a good crisis go to waste.” 27:41 “It's much easier in healthcare to build something new than to change something that exists.” 30:47 What benefits does telemedicine have to cutting administrative costs? 32:17 What is another significant benefit of using standardized contracts? 33:26 Why haven't standardized contracts become a common thing in the current healthcare system?   You can learn more by connecting with David on LinkedIn and following him on X (Twitter).   @David_Scheinker of @SURFStanfordMed discusses administrative burden on our #healthcarepodcast. #healthcare #podcast #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Dan Mendelson, Dr Benjamin Schwartz, Justin Leader, Dr Scott Conard (Encore! EP391), Jerry Durham (Encore! EP297), Kate Wolin, Dr Kenny Cole, Barbara Wachsman, Luke Slindee, Julie Selesnick

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.This week's Commercialization Weekly highlights Bristol Myers' success with a Kras drug trial, Astrazeneca's FDA approval for a rare disease drug acquired from Alexion, FDA approval for Akebia's anemia pill after a previous rejection, and Acorda's bankruptcy filing. The FDA is also set to make decisions on expanding the use of two multiple myeloma cell therapies, a top-selling medicine, and Pfizer's gene therapy work. Risant Health has launched after Kaiser closed the acquisition of Geisinger, with plans to acquire more nonprofits. Surescripts is reportedly exploring a sale, with a private equity buyer being a potential option.Genmab acquired ProfoundBio for $1.8 billion, joining the trend of increased M&A activity in the development of antibody-drug conjugates. Paragon's hub-and-spoke biotech model resulted in another reverse merger with Oruka Therapeutics going public. Diagonal has raised $128 million to develop more efficient 'activator' antibody drugs. A dementia-focused venture capital firm is exploring new brain drugs beyond anti-amyloid therapies. Roivant reported positive immune drug data and announced share buyback plans.Genmab recently acquired the company ProfoundBio for $1.8 billion, expanding its presence in the antibody-drug conjugate (ADC) space with a focus on gynecologic cancers and solid tumors. Meanwhile, Diagonal Therapeutics secured $128 million in funding for their unique approach to developing agonist antibodies for rare diseases. In other news, Vanda Pharmaceuticals received FDA approval for their antipsychotic drug Fanapt for bipolar disorder, while Eli Lilly's diabetes treatment Mounjaro will be in short supply due to high demand.The text discusses the impact of tensions in U.S.-China research and development (R&D) relations on the Chinese antibody-drug conjugate (ADC) investment boom. With the departure of Chinese biotech company Wuxi from Bio, concerns over national security implications of U.S.-China R&D relationships are growing. The text also mentions the appointment of a new CEO at Lonza and Avenzo's pursuit of a licensing strategy with a new $150 million investment. Overall, the biopharma industry is experiencing significant developments in drug development, mergers and acquisitions, and regulatory decisions. Stay updated with Healthcare Dive for more insights into healthcare trends and news.Thank you for tuning in to Pharma and Biotech daily. Stay informed!

The special episode of The Dish on Health IT episode provides insights and coverage from the recent HIMSS24 conference. Hosts Pooja Babbrah, the PBM and Pharmacy Lead and Jocelyn Keegan, Payer/Practice Lead with Point-of-Care Partners dig into their observation from HIMSS24 before reacting to stakeholder interviews from the floor of the Interoperability Showcase on topics ranging from the impact of the final CMS interoperability & prior authorization, benefits of API adoption and pharmacy interoperability opens with a montage of HIMSS24 attendees. --NOTE: The sound quality of the kiosk interviews is not ideal. If you prefer, you can watch this episode on video for close captioning of the kiosk interviews--The episode opens with a montage of HIMSS24 attendees sharing what they find valuable about attending HIMSS. Pooja Babbrah then opens the episode explaining that she and co-host Jocelyn Keegan share their key takeaways and insights from the biggest health technology conference in the industry. Jocelyn started the conversation off by sharing her observation that the work over the last 15 years to forge scalable connections to improve data fluidity has been fruitful and reached a tipping point. Importantly, the conversations we heard at HIMSS24 showed an acknowledgment as important as data fluidity is the content of what we are exchanging, and that data quality is just as important. Jocelyn then shared her second observation which is that we need to build a skillset and pool of resources who can do the next phase of work that is needed. She shared that when she worked in the financial industry which was at the time transitioning to interoperability and automation, they had to hire and develop the critical thinkers needed to think through how to best leverage technology, approach change management and do the abstractions needed to be successful. Health IT is at a similar place; we probably need more clinical informaticists because how we use technology in clinical workflows is extremely important, but we also need operational experts to help pull through how shifts in one workflow should get pulled through in others. She went on to say that we need people understand data mapping and why clean data is so important. Pooja thanked Jocelyn for her insights before sharing her own. She mentioned that she heard talk about whether ViVE and HIMSS could both survive because they occur so close together, and are big investments for companies to make to attend or exhibit. She shared that her view is that they are different enough in programmatic and attendance mix that she believes they both have value and will survive. Adding to Jocelyn's point about data quality, Pooja added that data governance and sending the right data to the right people at the right time versus just sending a data tsunami. Pooja continued by adding that it's also important to meet people where they are. This was clear at the post-acute care listening session. Some care facilities are not yet FHIR-enabled, some can send data via FHIR but perhaps are not yet API-enabled, how can we meet those facilities where they are even if they aren't using cutting-edge technology? Most stakeholders are going to be somewhere on a spectrum of tech adoption. We need to be flexible in how we do things. Pooja went on to say that another observation is that the importance of consent management will continue to grow, and that real work is starting to be done to figure out what patient-centered consent management might look like. We need to be able to exchange the right data at the right time with the right people, but we need to ensure we have the right consent to go along with it. Pooja mentioned some industry initiatives on consent including the HL7 FHIR at Scale Taskforce Accelerator, which has launched a new consent project. Public meetings for the FAST Consent project have launched and will be held regularly. A consent learning lab was held at HIMSS24 for the second year in a row. Pooja expressed that she attended both last year's and this year's events and she could feel a shift including the presence of regulators who were in the room. She explained that the conversation focused on actual work and progress being made in California and Florida as well as a huge focus on the role of consent in connecting health data and human services data.Next Pooja and Jocelyn listened and reacted to stakeholders who stopped by the POCP Kiosk in the Interoperability showcase to give their perspectives on the final CMS prior authorization & interoperability rule, API adoption, and pharmacy interoperability. Interviewees at the kiosk included:Colin Banas, Chief Medical Officer for DrFirst, shared insights on medication management and prior authorization.Polina Vaserman, Vice President of product Management with MHK, discussed the complexities and proposed improvements in prior authorization final rule.Lathe Bigler, Vice President of Clinical Network Services at First Databank provided perspectives on leveraging FHIR APIs for improving price transparency and patient care.Lenel James, Business Lead - Health Information Exchange & Innovation, Blue Cross Blue Shield Association, highlighted the use of FHIR APIs to enhance data accessibility for all stakeholders, including patients, payers, and providers, underscoring the importance of making healthcare data available across the care continuum to improve service delivery and care coordination.Melanie Marcus, Chief Marketing and Customer Experience Officer at Surescripts highlighted the role of pharmacies in expanding care access and the necessity for interoperability and policy support.Kathryn Ayers Wickenhauser, Sr. Director of Community Strategy at DirectTrust discusses the critical role of pharmacists in delivering care and the role of Direct Messaging can play in supporting this work. Themes from the interviews and host response include: CMS Interoperability and Prior Authorization: There has been broad acknowledgment of the positive progress this final rule will make towards enhancing interoperability and refining the prior authorization processes is widespread, with some hoping for additional policies to go even further.Healthcare Ecosystem and CMS Policies: The industry acknowledges the complexities of medications requiring prior authorization. There's an expectation for CMS to broaden its research and policy scope to include specialty medications, recognizing their critical importance.Impact of Technology and Innovation: The importance of adopting standards like FHIR for improving healthcare interoperability is emphasized. Leveraging technology and standard adherence is highlighted as crucial for enabling effective communication among healthcare stakeholders, reducing administrative burdens, and improving patient care quality.Pharmacy's Essential Role: Pharmacies are spotlighted as key to healthcare delivery, especially in underserved areas. There's strong advocacy for improved pharmacy interoperability and integration into the care team, stressing the need for policies, payment reforms, and access to health information to support their expanded role.Using Existing Technologies: The discussions promote the practical use of existing technologies and workflows to address healthcare delivery challenges effectively. This pragmatic approach centers on solving immediate patient care and business problems with available tools and sharing successful industry practices to foster broader adoption.Future Directions and Collective Engagement: A desire for ongoing engagement with health IT innovations, with a focus on interoperability, is clear in future industry events. The importance of collaborative efforts within the community and across the industry is underscored as critical for driving advancements in health IT and interoperability.After Pooja and Jocelyn listened and reacted to the interviews, Pooja shifted to close out the episode. She took a moment to reflect on the rich dialogue and insights shared by professionals across the healthcare ecosystem. She acknowledged the collective and collaborative effort that is fundamental to advancing health IT, underscoring the critical role of technology, the growing importance of pharmacies in the healthcare delivery ecosystem, and the collective anticipation for the evolution of policies concerning specialty medications and the work toward a better way to manage consent. With a nod to the resilience and spirit of innovation that defines the HIMSS conference, Pooja expressed gratitude for the contributions of all speakers and participants, celebrating another successful year of sharing, learning, and collaborating. Looking ahead with optimism, she voiced enthusiasm for the next HIMSS, where the community will reconvene to delve deeper into healthcare's pressing issues, explore new advancements, and foster further collaborations that promise to shape the future of health IT.

ePrescribing has become a norm in the US healthcare system. Now, the expanded role of pharmacists and the integration of non-physician prescribers into the healthcare system signifies a move towards a more accessible healthcare model, potentially alleviating some of the clinicians' burdens. Surescripts is the national provider of the ePrescribing infrastructure in the US. In this short discussion, I spoke with Dr. Lynne Nowak, Chief Data and Analytics Officer, and Melanie Marcus, Chief Marketing and Customer Experience Officer at Surescripts, about the importance of ePrescribing on a national level, the changing role of pharmacists, and how it facilitates the redistribution of healthcare provision burdens.  Newsletter: https://fodh.substack.com/ www.facesofdigitalhealth.com

Join us on the latest episode, hosted by Jared S. Taylor! Our Guest: Frank Harvey, CEO of Surescripts.What you'll get out of this episode:Discover Frank Harvey's journey from local pharmacist to healthcare industry leader.Insights into SureScripts' role in advancing healthcare connectivity.Discussion on the integration of technology in modern healthcare.Understanding the "Silver Tsunami" and its impact on health services.Frank Harvey's vision and strategic direction for the future of SureScripts.To learn more about SureScripts:https://surescripts.com/https://www.linkedin.com/company/surescripts-llc/Guest's Socials:LinkedIn: https://www.linkedin.com/in/frank-harvey/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Simplifying workflows and improving collaboration leads to better patient care. In this episode, we speak with Frank Harvey and Andrew Mellin from Surescripts about how their technology bridges communication gaps between pharmacists and other healthcare providers. We discuss innovations like price transparency, prescription quality improvements, and expanded clinical roles that empower pharmacists with the data they need at the point of care. Tune in to hear how Surescripts is connecting pharmacists with the broader care team and unlocking efficiency through better interoperability. https://surescripts.com/ [00:00:15] Introductions [00:01:07] Surescripts network overview [00:02:55] Industry adoption of healthcare IT [00:03:39] Slow areas of adoption [00:05:10] Benefits of digitized records [00:06:18] Players in the Surescripts network [00:07:43] Getting clinical data to pharmacists [00:08:44] Expanding pharmacists' clinical role [00:09:44] Pharmacist shortage and scope expansion [00:10:11] Interoperability vision [00:12:26] Facilitating seamless claims processing [00:13:39] Accessing patient records [00:14:08] Clinical data exchange examples [00:15:59] Evolution of pharmacy practice [00:17:03] Surescripts and prescription payments [00:18:42] Role in claims adjudication [00:20:41] Involvement in billing process [00:21:52] Improving prescription quality [00:23:07] Centralized patient database [00:24:01] Drug shortage database potential [00:25:50] Addressing drug shortages with standards [00:27:05] Providing drug availability info to prescribers [00:28:23] Simplifying prescription instructions [00:29:20] Healthcare interoperability challenges [00:30:08] Prescription abandonment with price transparency [00:32:07] Price transparency at prescribing [00:33:19] Evolution of prescribing complexity [00:35:47] Structuring prescription instructions [00:36:47] Improving prescription quality [00:38:22] Recapturing provider-pharmacist conversations [00:39:23] Adapting to industry changes [00:40:03] Pain points in the job [00:41:54] Choosing priority focus areas [00:43:18] Identifying industry needs and ideas [00:44:27] Embedding in end-user workflows [00:45:53] Closing remarks The Business of Pharmacy Podcast™ offers in-depth, candid conversations with pharmacy business leaders. Hosted by pharmacist Mike Koelzer, each episode covers new topics relevant to pharmacists and pharmacy owners. Listen to a new episode every Monday morning.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.In today's episode, we have several news updates from the industry. Let's dive right in!First up, we have a webinar titled "Navigating Preclinical Drug Development Challenges with Lipid-Based Formulations." This webinar discusses how biopharma teams are utilizing lipid-based formulations (LBF) to improve the bioavailability of challenging molecules and reduce the transition time and cost requirements for clinical trials. The highlights of the webinar include strategies for dosing lipid formulations in preclinical models, key considerations for improving bioavailability through LBF, and the regulatory and technical nuances involved in transitioning preclinical LBF to viable clinical dosage forms.Next, we have a case study from Cambrex on their process to enable GMP production under tight time pressure for a first-in-human clinical trial. This case study highlights the importance of route development and designing synthesis for GMP production. Cambrex's experts successfully developed a robust and high-yield process to enable GMP production within a tight timeline for a first-in-human clinical trial.Moving on, Biogen and Sage have set the price of their postpartum depression pill at $15,900, which is significantly lower than initial predictions. This move aims to make the treatment more accessible to patients. Additionally, obesity drug biotech startup OrsoBio has raised $60 million in a series A funding round to develop new therapies for obesity and related metabolic disorders.In another news update, Anne Wojcicki, CEO of 23andMe, discusses the company's transition into a "full-fledged biotech" in an in-depth interview. Wojcicki explains how 23andMe is venturing into drug research and development, going beyond its initial focus on at-home genetics testing. Ventyx, a biotech company, has revised its plans for its tyk2 drug after lackluster study data, and Bristol Myers is paying $100 million for access to a blood and bone marrow cancer drug developed by Orum Therapeutics.Shifting gears, the Biden administration is proposing a rule to cap broker payment in Medicare Advantage (MA) plans in Massachusetts to prevent marketing misconduct. Kaiser Permanente reported a rebound in investment and operating income in Q3, Envision Healthcare has emerged from bankruptcy restructuring, and Surescripts has acquired drug alternatives company ActiveRadar.Hospitals are also facing challenges in preparing for extreme weather events caused by climate change. Financial and data challenges are making it difficult for hospitals to develop effective disaster planning strategies. In other news, Cigna is reportedly exploring the possibility of shedding its Medicare Advantage business, and there is an ongoing battle over drug prices between Secretaries Becerra and Azar. A new California law offers protection from steep ambulance bills.Moving on to the pharmaceutical industry, Novartis has signed a potential $1.3 billion deal with Chong Kun Dang Pharmaceutical for the global rights to develop an oral HDAC6 inhibitor. Ventyx Biosciences has decided to discontinue the development of its psoriasis candidate despite positive results in a phase II study. Vertex Pharmaceuticals reported third-quarter revenue of $2.48 billion, falling short of expectations. The Department of Health and Human Services is considering removing Johnson & Johnson's psoriasis treatment Stelara from Medicare drug price negotiations.Next, we have an article discussing Anne Wojcicki, CEO and founder of 23andMe, and her ambitions to disrupt the healthcare industry through genomics. Wojcicki's interest in healthcare began during her childhood, and she has positioned 23andMe as a leader in direct-to-consumer genetic testing and genetic data partnerships with pharmaceutical companies. The article highlights an in-depth interview with Wojcicki, wher

November 6: Today on the Conference channel, it's an Interview in Action live from HLTH with Frank Harvey, CEO of Surescripts. They discuss the challenges of physician burnout and the role of data collection in healthcare. The conversation highlights the need for solutions to reduce administrative tasks for physicians and the potential of expanding the care team to include pharmacists. They also explore the integration of AI in healthcare and emphasize the importance of careful implementation. Can data collection and AI help alleviate physician burnout? How can expanding the care team improve patient care?Subscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

In this episode of MGMA's Business Solutions podcast, we speak with Dr. Romi Chopra. Dr. Chopra is President and CEO of the Midwestern Institute for Minimally Invasive Therapies (MIMIT) or MIMIT Health—one of the fastest growing physician groups in Illinois. Dr. Chopra attended Harvard Medical School, was an Interventional Radiology Fellow at Brigham and Women's Hospital, and was Awarded the Distinguished Physician Award and U.S. Congressional Medal for Excellence in 2018. Resources Discussed: * Dr. Romi Chopra: https://www.drromichopra.com/about-dr-chopra * Mimet Healthcare: https://mimithealth.com/ * Surescripts: https://surescripts.com/?utm_campaign=2018_Brand&utm_source=google&utm_medium=cpc&utm_content=677041874376&utm_term=surescripts&adgroup=Surescripts&gclid=Cj0KCQjwhL6pBhDjARIsAGx8D58QozVU-oHDkQvUl8S0tje0g11JoHmOcLvy2RWI8J6ZB4CW0dO4N9caAjapEALw_wcB Additional Resources: MGMA Leaders Conference registration: mgma.com/conferences/leaders/register Leaders Conference Schedule: mgma.com/conferences/leaders/schedule Conference Overview: mgma.com/conferences/leaders/overview

In a recent survey, Surescripts found growing support for pharmacists to prescribe a select number of medications to patients, thus easing the workload on physicians. Technologies like direct messaging and record sharing is making this possible. Healthcare IT Today reached out to Surescripts and Frank Harvey, CEO of Surescripts agreed to come on camera to discuss the survey's findings. Learn more about Surescripts at: https://surescripts.com/ Find more great health IT content at https://www.healthcareittoday.com/

In this 10 minute conversation Frank Harvey, Chief Executive Officer of Surescripts, tells us about how interoperability is becoming more of a reality. Tuned in to learn more on expanding access to primary care and much more.This episode is sponsored by Surescripts

All aboard! If you want to bring any strategic vision to fruition, you need to bring everyone along with you—from the CEO, to the executive team, to employees throughout the org. That's what we explore in today's episode with CMOs Melanie Marcus of Surescripts, Grant Johnson of Billtrust, and Lauren Boyman of KPMG US.  All three have led impressive strategic initiatives at their respective orgs, and in this conversation, they share the behind the scenes work that it takes to get there. Tune in to as they share how to navigate corporate dynamics, win over the skeptics, and get consensus for the big ideas that will move the needle. For full show notes and transcripts, visit https://renegade.com/podcasts/ To learn more about CMO Huddles, visit https://cmohuddles.com/

Scott Barclay, Managing Director at Insight Partners, delves into the potential of software to revolutionize healthcare's flawed systems. He explores the dynamics of VC firms operating across various stages in the ecosystem, weighing the pros and cons of seed-stage investments for larger firms. Additionally, Scott shares insights on why now is an opportune time to embark on AI endeavors.In this episode, you'll learn:[3:47] What approaches is Insight Partners employing to establish the most scalable framework as a leading global software investor?[7:32] A VC's reputation is built on their interactions with founders, regardless of whether or not they get on the founder's cap table.[11:29] Genuine success narratives within healthcare emerge at the crossroads of empathetic product development and high-quality go-to-market strategies.[16:10] 2023 to 2025 will be a phenomenal time to start something in AI.[24:56] Certain occasions demand the recognition that achieving greatness requires strategic boldness and the willingness to take early leaps.The non-profit organization that Scott is passionate about: Camp JabberwockyAbout Scott BarclayScott Barclay is a managing director for the health practice at Insight Partners. He's focused on how teams—armed with technical prowess and an earned empathy to the problem—can build something greater than themselves in healthcare with software and data. Previously, Scott was a partner at DCVC, an angel investor, and an operator at Surescripts. He has been instrumental in Insight's investment in UnoBravo, Kintsugi, Trialjectory, IDOVEN, AiVF among others.About Insight PartnersInsight Partners is a New York-based global software investor that partners with growth-stage technology and software companies, with a deep focus in Fintech, Cybersecurity, AI/ML, DevOps, and Healthcare sectors. Insight's portfolio companies include wiz, Calm, Checkout, Divvy, Kaseya, Espressive, ncino, onetrust, Pluralsight, among others.Subscribe to our podcast and stay tuned for our next episode. Follow Us:  Twitter | Linkedin | Instagram | Facebook

Host Eric Thrailkill, and Project Healthcare team member, Lauren Hatcher, are joined by Seth Joseph, Founder and Managing Director of Summit Health Advisors, to discuss how his background as a strategy officer and involvement in building a two-sided marketplace in healthcare has enabled him to continue to provide support services in a boutique category of platform business models. With more than a decade leading strategy for innovative digital health companies, including CVS Health and Surescripts, Seth founded Summit Health Advisors in 2018 with a goal to make it easier for digital health companies, hospitals, and investors to find a true strategic partner. 

https://surescripts.com/news-center/press-releases/detail/surescripts-names-frank-harvey-as-new-ceo-to-lead-company-through-continued-growth-and-new-opportunities-to-impact-healthcare ARLINGTON, Va. – June 6, 2022 – Surescripts, the nation's leading health information network, has appointed Frank Harvey as Chief Executive Officer, effective June 27. Harvey succeeds Tom Skelton, who previously announced his decision to retire. Harvey is a pharmacist and an experienced chief executive and investor and has held numerous senior leadership roles during his more than 35-year career in the healthcare technology, pharmacy and pharmaceutical sectors. Harvey joins Surescripts from ATLS Investments, LLC. where he led private equity investing in healthcare technology companies. Previously, Harvey served as Chief Executive Officer of Mirixa Corporation and Liberty Medical Supply, Inc. “It's been a pleasure to work closely with Tom over the past eight years, and we appreciate the many successes that Surescripts achieved under his leadership,” explained Steven Miller, MD, Co-Chair of Surescripts' Board of Directors. “We are now poised for continued growth and new opportunities with Frank's leadership at this incredible time in healthcare.” “Frank is a results-oriented leader with strong operational skills, and extensive experience growing healthcare businesses,” said Douglas Hoey, Co-Chair of Surescripts' Board of Directors. “Frank combines his unique perspective and depth of experience with a passion for improving the lives of patients and evolving the healthcare system.” “I'm honored to join Surescripts at such a critical time, and I look forward to working with the team to realize the enormous potential we have to change healthcare,” Harvey shared. “I'm committed to what we do as a company and the new products and services we will bring to market that I believe will have a significant impact on the healthcare system as a whole.”

This is a Tuesday Tips episode where you will hear host Drew Neisser, CMOs, and other B2B experts share their hard-earned wisdom and fresh marketing insights in a bitesize format. Featuring: Janet Jaiswal of Cloudbeds, Melanie Marcus of Surescripts, Josh Machiz of Redpoint Ventures, Megan Galvin of New State Capital Partners, and Mary Leigh Mackie To see the video versions, follow Drew Neisser on LinkedIn or visit our YouTube channel—The Renegade Marketing Hub! And if you're a B2B CMO, check out our thriving community: https://cmohuddles.com/​​

May 30: Walk the floor with This Week Health. Check out the booths you may have missed at the spring health IT conferences. In this episode we feature:Andrew Murray, Senior Director at Zynx Health Andrew Royce, CEO at VoyceRyan Smith, Director, Content Marketing at Extreme NetworksAmit Khanna, SVP & GM, Health and Life Sciences at SalesforceAndrew Mellin, MD, VP, CMIO at SureScriptsJoin us on June 8 at 1PM ET for our webinar: 'The Future of Care Spaces' This webinar will focus on the latest healthcare technologies and solutions transforming care spaces in America. Care spaces can include hospitals, clinics, and at-home treatments where advanced technologies can enable better workflows, treatments, and patient outcomes. Register Here: https://thisweekhealth.com/future-of-care-spaces/Subscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Show Notes: John Driscoll is the President of Walgreens Boots Alliance and the co-host of the second largest healthcare podcast on YouTube, CareTalk. In this episode, host Will Bachman welcomed John to the show. John has extensive experience in the healthcare industry, having played a leading role in creating successful companies like MedCo, Surescripts, Oxford Health Plans, and Care Centrix. John discusses topics such as monkeypox, mask mandates, baby formula shortages, Silicon Valley Bank's failure, and healthcare related topics. He also shares his  opinions on a variety of healthcare issues.  The Future of Pharmacies  John started his career in health care after being influenced by his mother, a nurse. After college, he developed housing programs for homeless and mentally ill people. He then became a management consultant, before moving to Asheville Health Plan. He has worked in multiple parts of the health industry spectrum, gaining experience in Medicare and Medicaid.  He has found his career to be full of big and challenging problems, but is motivated to improve the world and create successful businesses. His main initiatives involve investing in Village MD, Summit, and Espadin Shield Specialty Pharmacy to show how an integrated pharmacy and clinical model can improve outcomes at lower cost. Walgreens is also working with health plans and has 9000 stores and 90,000 clinicians to provide access and convenience, trust, and traffic. Their goal is to become essential in healthcare by leveraging their expertise in retail and pharmacy services. He discusses how pharmacies can become better partners to health plans by taking advantage of their advantages in brand marketing, trust, convenience, and patient specificity. He shares  a specific example of how a large regional health plan achieved a return rate of three times greater on colorectal screenings than before they partnered with the pharmacy. The pharmacy was also able to increase the rate of colorectal screenings up to 51% in underserved areas due to the support of non-clinical personnel in their stores. Additionally, the pharmacy is partnering with health plans to reduce admissions to nursing homes by 20% through nurse visits, follow-ups, and care navigation. The system leads to better patient and contact information.  Overall, the pharmacy is providing an invaluable service in helping health plans lower costs while improving outcomes. He explains how his company invests in bespoke automation machines to allow pharmacists to spend more face-to-face time with patients, and how pharmacists could be more involved and take on more responsibility in the treatment of patients and how this would expand access to more care in an overburdened health system. Pharmaceutical Healthcare,  the Pandemic, and Value-based Care John reflects on  health regulations and restrictions and also the risk taking and flexibility that came into place under the COVID pandemic. He confirms how important it is to prepare for pandemics in terms of vaccine supplies, communication, and pre-deploying and integrating national and state employees in operations. He also notes the critical role of pharmacies in crisis situations. He tackles the issue of employee burnout and the current pharmacist shortage and the steps Walgreens is taking to solve the problem across states. On value-based care, he explains how it is the future, especially in the U.S. where healthcare is more expensive than any country in the world, how this is unacceptable, and how this should be approached to address health issues earlier to avoid hospitalization.  The CareTalk Podcast  John talks about the inspiration and intention of his podcast, what the content is and what has surprised him throughout the conversations. Guests that have been on his podcast include Andy Slavitt, Zeke Emanuel, Tony Cosgrove, and Amy Abernathy. When asked what he learned from his guests,  John shares that he was surprised to find out that even though healthcare is very complicated and people are in silos, there is still room for novel and provocative opinions that can be explained. He also found out that everybody knows that drug costs are too high, but there are practical ways to bring them down without destroying the biotechnology industry that is creating new drugs to cure aging and extend lifespans.  The podcast explores various issues surrounding health care and how to best address them. Toby Cosgrove from the Cleveland Clinic brought up the importance of creating heart-centered care in a large inner city hospital. It was noted that there are a lot of people working on solutions to healthcare problems, such as telehealth and AI to solve labor shortages. He also touches on the potential for AI and Chat GPT to be used in health care. While it is still early days, he mentions that there have been some companies experimenting with using these tools. Health Care and AI John talks about the impact of artificial intelligence on healthcare. He believes that AI has the potential to reduce administrative costs and waste in healthcare by simplifying billing and reconciliation processes. He also believes that AI can help in drug discovery, clinical pathways, and personalized care.  He is looking forward to having guests on CareTalk with whom he can discuss the economy, healthcare costs, and the pandemic's effect on inflation. He wants to discuss  the current chaotic economic landscape that is impacting healthcare, and the labor industry in particular. He mentions the growth of traveling nurses who are paid by private equity firms and how hospitals have had the worst six months financially in US history. He sources his information from HealthTech Nerds,  the Washington Post, New York Times, LA Times, Wall Street Journal, Health Affairs, and Jim and Science,  the MIT Tech Review, Science and Cell, all as good sources of information. He suggests Kaiser Family Foundation and Kaiser Health News as exceptional sources, as well as government sources such as CMS for basic data. Timestamps 03:20 Walgreens Boots Alliance's Healthcare Initiatives 06:35 Partnering with Health Plans to Improve Outcomes and Lower Costs 09:52 Improving Patient Care Through Pharmacist Interaction 10:48 Automated Fulfillment Centers and Patient Care at Walgreens 28:45 Healthcare Innovations  31:54 Exploring Solutions to Healthcare Challenges 32:15 The Impact of Artificial Intelligence on Healthcare  36:49 Exploring the Impact of the Changing Labor Industry on Healthcare  Links: https://www.caretalkpodcast.com/ https://www.walgreens.com/ Unleashed is produced by Umbrex, which has a mission of connecting independent management consultants with one another, creating opportunities for members to meet, build relationships, and share lessons learned. Learn more at www.umbrex.com.

Welcome to the second season of There's a Better Way: Smart Talk on Healthcare and Technology, an award-winning podcast series from Surescripts. In each episode, host Melanie Marcus, Chief Marketing Officer of Surescripts, sits down with some of the most inspiring leaders in healthcare today for in-depth and personal conversations about the industry's challenges and opportunities. By the end of each episode, you'll walk away with real-world stories—stories that show a better way to tackle healthcare's most stubborn issues as well as what the future might hold for an industry undergoing rapid change. If you're up for smart, energizing and story-driven conversations with some of the nation's top leaders in healthcare and technology, tune into There's a Better Way, premiering on all major podcast apps this April. Learn more—check out the whole first season.

This episode of the Surescripts Podcast Series will focus on the evolving role of the pharmacist in care for patients with multiple sclerosis, specialty patient access to care, and the improvement Surescripts is seeing through the use of electronic solutions. Specifically, the podcast guests will dive into how specialty pharmacists help patients achieve the best health outcomes by providing timely prescriptions, helping pharmacies and patients manage care. Finally, the episode will highlight how tools at the pharmacy (Specialty Patient Enrollment, Electronic Prior Authorization, Specialty Medications Gateway) enable patients to start therapy faster and give specialty pharmacists more time to serve as trusted partners and resources for patients with serious and complex illnesses.  

February 24, 2023: The nature of healthcare is changing and many, including Frank Harvey, CEO of Surescripts, have some predictions. Physicians will take up the role of primary care provider once again and the legislature will shift to aid in preventing physician burnout. This is a big problem because what happens when 150,000 physicians pull out of the occupation? How will these transitions impact the big players like CVS and how will it impact IDNs? With pharmacists peaking patient's trust and time, we need to better our compensation structures and legislature. What does the new competition in the field, Walmart and Minute Clinic mean for healthcare? How will hospitals grow their interoperability? Will specialty medications play an even larger role? There is a cooperative future in healthcare and we are working towards closer working relationships all over. Key Points:20% of primary care physicians plan to retire over the next two years.In the first half of this year, over 10 and a half million messages have gone back and forth between physicians and pharmacistsThe pharmacists see patients on average 35 times a year while their primary care doctor sees them only 4 on average.30% of rural healthcare systems will close within the next year21st Century Cures' requirements on the providers and payersSurescriptsHealthcare needs innovative ways to address staffing shortages from clinical to IT employees. Are you curious about how technology can help support your Healthcare staff? Join us on our March 9 webinar, “Leaders Series: The Changing Nature of Work,” to explore how Health IT can be used to supplement Healthcare professionals https://thisweekhealth.com/leaders-series-the-changing-nature-of-work-remote-hybrid-onsite-shortages/Subscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

In 2023, leaders in health IT analytics, mHealth, EHR, and health IT security will see innovation around healthcare consumerism and provider burden. Experts from HITRUST, Surescripts, Mass General Brigham Health System, and Mayo Clinic Platform share their projections for the new year. Multimedia Manager's Note (1/17/2023): This is an updated version of the podcast episode that went live on January 16, 2023. The original version misattributed some of the guests. The guests in order of appearance are: - Frank Harvey, chief executive officer of Surescripts, - John Halamka, MD, president of Mayo Clinic Platform - Lee Schwamm, MD, vice president of digital patient experience at Mass General Brigham Health System - Robert Booker, chief strategy officer and executive vice president of the center of excellence at HITRUST

In this episode of the MGMA Business Solutions podcast, we're joined by Bri Palowitch, clinical informatics pharmacist at Surescripts and Scott Rochowiak, manager of product performance at Surescripts. In this thought leader discussion, we discuss issues with prescription quality workflow disruption and examine solutions for those problems. Resources from this episode: Surescripts: https://surescripts.com/ Additional Resources: MGMA Member Network -- https://www.mgma.com/membership?utm_campaign=membership&utm_medium=cpc&utm_source=ppc-membership-search-dm-ng&url=https://www.mgma.com/membership/memberships/individual%3Futm_campaign%3Dmembership%26utm_medium%3Dsearch%26utm_source%3Dppc-membership-search-dm-ng&gclid=Cj0KCQiA_P6dBhD1ARIsAAGI7HBZWw8Dxb0SVsjIqaniK7TiRzb8ZEbexcfHF_eRPUDEINSExXAxxRgaAhtKEALw_wcB MGMA DataDive: https://www.mgma.com/data/landing-pages/mgma-datadive-overview?utm_campaign=data&utm_medium=cpc&utm_source=ppc-datadive-overview-dm-ng&url=https://www.mgma.com/data/landing-pages/mgma-datadive-overview%3Futm_campaign%3Ddata%26utm_medium%3Dsearch%26utm_source%3Dppc-datadive-dm-ng&gclid=Cj0KCQiA_P6dBhD1ARIsAAGI7HAVkvyRPorbpHYHRQBVsV4N2DyrM97sDInjNePQnFteAW-kQud21W4aAt-GEALw_wcB Sponsor: This episode is brought to you by the Medical Practice Excellence: Financial and Operations Conference 2023. During our premiere spring event, attendees will gain key insights from both disciplines and learn about topics that shape the future success of medical practice organizations. Go to mgma.com/mpe23 to learn more and to register today. If you would like additional tools and resources related to medical practice leadership email us at podcasts@mgma.com. Thank you again for taking the time to listen to MGMA's Insights podcast. If you have opportunities you'd like to share with the MGMA audience, go to www.mgma.com/marketing-with-mgma/advertise to find out how you can connect with the MGMA audience.

This is a Tuesday Tips episode where you will hear host Drew Neisser, CMOs, and other B2B experts share their hard-earned wisdom and fresh marketing insights in a bitesize format. Featuring: Carlos Carvajal of Q2, Melanie Marcus of Surescripts, Sue Holub of OnSolve, Oliver Nutt of General Dynamics, Chandar Pattabhiram of Coupa, Kristin Fornal of Brand pH LLC, and Michael O'Connell. To see the video versions, follow Drew Neisser on LinkedIn or visit our YouTube channel—The Renegade Marketing Hub! And if you're a B2B CMO, check out our thriving community: https://cmohuddles.com/​​

In this week's episode, Surescripts CEO Frank Harvey discusses how Surescripts is improving healthcare data interoperability and better empowering pharmacists to provide primary care to patients.

In this episode, we are joined by Andrew Borgschulte, Principal Product Marketing Manager at Surescripts, to discuss CMS star ratings and HEDIS scores and why these measures are so meaningful. Tune in to learn how interoperability can support health plans in achieving higher star ratings and HEDIS scores, and how to improve access to patient health information in a provider's workflow. Hear insights on how access to the right data and analysis influences patient care and health outcomes. This episode is sponsored by Surescripts.

Welcome to our Unlocking Brand series, where our global brand experts host live case studies, deliver actionable insights, and answer key questions on the topics that matter to brand marketers today. In this episode, Melanie Marcus, CMO, Surescripts, the nation's leading health information network, joins our colleagues Brian Rafferty, Global Head of Research & Insights, and Margaret Molloy, Global CMO, for an in-depth conversation that explores how to leverage brand as a tool to inform your overall strategy.

There is a lot at stake and much to coordinate for a specialty patient. With specialty prescribers trying to provide a personalized experience for patients and specialty pharmacies expected to respond 24/7 and facilitate timely, accurate delivery, how do specialty stakeholders do it all and provide a positive patient experience? In this episode of Un-Scripted with Surescripts, we will explore the value-add services pharmacies and providers strive to give patients, hearing from Kroger Specialty and eMDs about how they aim to delight and deliver. The episode will focus on efficiencies being gained in specialty prescribing and fulfillment with partners like Kroger Specialty and eMDs. eMDs is automating the process of sending clinical information from the prescriber to the pharmacy Kroger Specialty is soon implementing solutions to streamline access to clinical information and has a focus on hands-on facilitation of filling specialty prescriptions to best serve patients   Guests: Alexis Wiles, PharmD, Clinical Pharmacist Liaison Supervisor, Kroger Specialty Cecelia Byers, PharmD, Clinical Product Manager, Surescripts (white black dress)  David Weigan, Project Manager, eMDs

If only the prescription workflow were as simple as: Signed, sealed, delivered. But there are many issues that can arise requiring pharmacist intervention and prescriber approval. With standards like CancelRx in place, clinicians can help ensure patient safety. This episode of Un-Scripted will dive into how patients and clinicians alike benefit from the use of electronic standardization measures that address prescription change management, Sig quality issues, and safe prescription fulfillment. We'll hear from Dr. Danny Lee, CMIO, Johns Hopkins Community Physicians, and Lawrence King, Manager of Clinical Informatics and Patient Safety for Surescripts, who will share their insights into how adoption of these standards is paving the way for greater interoperability and patient safety. Learn more about your ad choices. Visit megaphone.fm/adchoices

This is a Tuesday Tips episode where you will hear host Drew Neisser, CMOs, and other B2B experts share their hard-earned wisdom and fresh marketing insights in a bitesize format. Featuring: Simon Schaffer-Goldman of Case Paper, Heidi Bullock of Tealium, Dan Lowden of HUMAN, Marshall Poindexter of Cadence Design Systems, Steven Duque of Pearl Health, Andrew Hally of Markforged, Patti Newcomer-Small of FieldRoutes, Ajay Khanna of Mezmo, Melanie Marcus of Surescripts, and Cynthia Crossland of Constella Intelligence. To see the video versions, follow Drew Neisser on LinkedIn or visit our YouTube channel—The Renegade Marketing Hub! And if you're a B2B CMO, check out our thriving community: https://cmohuddles.com/​​

In this episode of the Post-Acute POV, our host Navin Gupta, SVP of the home and hospice division at MatrixCare, is joined by Bri Palowitch, PharmD, account manager for health plans, and Andrew Borgschulte, principal product marketing manager, Surescripts. The three have a conversation on the value of creating an open network and ecosystem and how the partnership between MatrixCare and Surescripts accomplishes this goal. Join Bri, Andrew, and Navin as they discuss Surescripts’ mission of aligning healthcare organizations across the U.S. to simplify the way health intelligence is shared, the development and impact of medication import and reconciliation features, and the role of data as actionable intelligence and how this data is inherent in supporting practical interoperability. Listen to their discussion below. Topics discussed during today’s episode: [00:38 – 02:26]: Navin introduces the episode’s topic and Andrew provides background on his experience in healthcare IT. [02:50 – 05:12]: Andrew shares details about the work that Surescripts leads—aligning healthcare organizations across the U.S. to simplify the way health intelligence is shared. He also details how their partnership with MatrixCare benefits both of our end users. [6:27 – 11:42]: Bri details her background as a Board-Certified Geriatric Pharmacist, among other impressive roles, and shares two stories on the development and impact of Surescripts’ medication import and reconciliation features. Both tales shed light on how these solutions are bringing positive change to provider care and patient impact. [13:22 – 17:06]: Andrew explains the role of data as actionable intelligence, how this data is inherent in supporting practical interoperability, and why Surescripts is committed to getting the right data into the hands of our shared customers. [17:06 – 18:44]: Bri lends her view as a clinician to the conversation by discussing the importance of making data consumable. She explains why an EHR is incredibly helpful in organizing data and communicating it in an easy-to-understand way. Resources Learn more about MatrixCare: https://www.matrixcare.com/ Find out more about Surescripts: https://surescripts.com/ Read the transcript of today’s episode Listen to more episodes of the Post-Acute POV Disclaimer The content in this presentation or materials is for informational purposes only and is provided “as-is.” Information and views expressed herein, may change without notice. We encourage you to seek as appropriate, regulatory and legal advice on any of the matters covered in this presentation or materials. ©2022 by MatrixCare

TIME recently named Walgreens one of the 100 Most Influential Companies of 2022, noting that as of March 2022, the company had administered 60 million COVID-19 vaccines and 26 million tests. In this episode, host Melanie Marcus, Chief Marketing Officer of Surescripts, sits down with a guest who has had a truly noteworthy career, beginning as a cashier at the Walgreens across the street from her high school before rising through the ranks to become Vice President for Pharmacy Quality, Compliance and Patient Safety at the company. Today, Tasha Polster has overseen the national rollout of the COVID-19 vaccine in thousands of stores across the country. As a healthcare leader who is helping to reimagine how care can and should be delivered in this “new normal,” Tasha shares her inspiring story, and her perspective on the value of innovation, collaboration and partnership during challenging times.

This is a Tuesday Tips episode where you will hear host Drew Neisser, CMOs, and other B2B experts share their hard-earned wisdom and fresh marketing insights in a bitesize format. Featuring: Ajay Khanna of Mezmo Heather Salerno of Appcast, Melanie Marcus of Surescripts, Peter Finter of CyberGRX, and special guest, Alan Hart. To see the video versions, follow Drew Neisser on LinkedIn or visit our YouTube channel—The Renegade Marketing Hub! And if you're a B2B CMO, check out our thriving community: https://cmohuddles.com/​​

Welcome to "There's a Better Way: Smart Talk on Healthcare & Technology", a new podcast series by Surescripts. In each episode, host Melanie Marcus, Chief Marketing Officer of Surescripts, sits down with some of the most inspiring leaders in healthcare today for in-depth and personal conversations about the industry's challenges and opportunities. Through this podcast, you'll be exposed to new perspectives on stubborn healthcare challenges, how technology can be used to improve care and what the future might hold for an industry in the midst of rapid change. If you're up for smart, energizing and story-driven conversations with some of the nation's top leaders in healthcare and technology, tune into There's a Better Way, premiering on all major podcast apps this summer. Learn more.